Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease

Trends in Cell Biology

Volumn 12, Issue 12, 2002, Pages 605-613

  Marks, David L ^a   Pagano, Richard E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID; SPHINGOLIPID; CHOLESTEROL; RAB PROTEIN;

CELL SELECTION; ENDOCYTOSIS; ENDOSOME; GOLGI COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; STORAGE DISEASE; ANIMAL; BIOLOGICAL MODEL; LIPIDOSIS; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; ENDOCYTOSIS; GLYCOSPHINGOLIPIDS; HUMANS; MODELS, BIOLOGICAL; RAB GTP-BINDING PROTEINS; SPHINGOLIPIDOSES;

EID: 0036901168     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)02399-1     Document Type: Review

References (70)

1. Kolesnick R.N., et al. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184:2000;285-300.
2. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18:1998;1523-1533.
3. Shayman J.A. Sphingolipids. Kidney Int. 58:2000;11-26.
4. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:2000;17221-17224.
5. Brown R.E. Sphingolipid organization in biomembranes: what physical studies of model membrarnes reveal. J. Cell Sci. 111:1998;1-9.
6. Rietveld A., Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta. 1376:1998;467-479.
7. Sandhoff K., et al. Sphingolipid activator proteins. Scriver C.R., et al. The Metabolic and Molecular Bases of Inherited Disease. III:2001;3371-3388 McGraw-Hill.
8. Butters T.D., et al. Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders. Chem. Rev. 100:2000;4683-4696.
9. Scriver C.R., et al. Part 16: Lysosomal enzymes. The Metabolic and Molecular Bases of Inherited Disease. III:2001;3371-3894 McGraw-Hill.
10. Bach G. Mucolipidosis type IV. Mol. Genet. Metab. 73:2001;197-203.
11. Chen C.S., et al. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6373-6378.
12. Ko D.C., et al. Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol. Biol. Cell. 12:2001;601-614.
13. Neufeld E.B., et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274:1999;9627-9635.
14. Patterson M., et al. Niemann-Pick disease type-C: a lipid trafficking disorder. Scriver C.R., et al. The Metabolic and Molecular Bases of Inheritied Disease. III:2001;3611-3634 McGraw Hill.
15. Schuchman E.H., Desnick R.J. Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. Scriver C.R., et al. The metabolic and molecular bases of inheritied disease. III:2001;3589-3610 McGraw Hill.
16. Chen C.S., et al. A broad screening test for sphingolipid storage diseases based on alterations in lipid trafficking. Lancet. 354:1999;901-905.
17. Choudhury A., et al. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109:2002;1541-1550.
18. Puri V., et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid storage diseases. Nat. Cell Biol. 1:1999;386-388.
19. Puri V., et al. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J. Cell Biol. 154:2001;535-547.
20. Sun X., et al. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Am. J. Hum. Genet. 68:2001;1361-1372.
21. Vered A., et al. Fluorescence-based diagnosis of lipid storage diseases by analysis of the culture medium of skin fibroblasts. Clin. Chim. Acta. 218:1993;139-147.
22. Sugimoto Y., et al. Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann-Pick C1-deficient cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12391-12396.
23. Martin O.C., et al. Cholesterol deprivation affects the fluorescence properties of a ceramide analog at the Golgi apparatus of living cells. Proc. Natl. Acad. Sci. U. S. A. 90:1993;2661-2665.
24. Leventhal A.R., et al. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. J. Biol. Chem. 276:2001;44976-44983.
25. Grimmer S., et al. Endosome to Golgi transport of ricin is regulated by cholesterol. Mol. Biol. Cell. 11:2000;4205-4216.
26. Zhang M., et al. Sterol-modulated glycolipid sorting occurs in Niemann-pick C1 late endosomes. J. Biol. Chem. 276:2001;3417-3425.
27. Sillence, D.J. et al. Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res. (in press).
28. van Echten-Deckert G., et al. Turnover of endogenous ceramide in cultured normal and Farber fibroblasts. J. Lipid Res. 38:1997;2569-2579.
29. Chen W.W., Decker G.L. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease. Biochim. Biophys. Acta. 718:1982;185-192.
30. Kobayashi T., et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell Biol. 1:1999;113-118.
31. Mukherjee S., Maxfield F.R. Cholesterol: stuck in traffic. Nat. Cell Biol. 1:1999;E37-E38.
32. Pagano R.E., et al. Membrane traffic in sphingolipid storage diseases. Traffic. 1:2000;807-815.
33. Simons K., Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol. 10:2000;459-462.
34. Duchemin A.M., et al. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 81:2002;696-707.
35. Hakomori Si S.I. Inaugural article: the glycosynapse. Proc. Natl. Acad. Sci. U. S. A. 99:2002;225-232.
36. Iwamoto T., et al. Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-κB ligand. J. Biol. Chem. 276:2001;46031-46038.
37. Hannun Y.A., et al. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry. 40:2001;4893-4903.
38. Spiegel S., et al. Sphingosine 1-phosphate signaling: providing cells with a sense of direction. Trends Cell Biol. 12:2002;236-242.
39. Anderson R.G. The caveolae membrane system. Annu. Rev. Biochem. 67:1998;199-225.
40. Johannes L., Lamaze C. Clathrin-dependent or not: is it still the question? Traffic. 3:2002;443-451.
41. Nichols B.J., Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol. 11:2001;406-412.
42. Pelkmans L., et al. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science. 296:2002;535-539.
43. Sabharanjak S., et al. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell. 2:2002;411-423.
44. Tran D., et al. Ligands internalized through coated or uncoated invaginations follow a common intracellular pathway. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7957-7961.
45. Orlandi P.A., Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141:1998;905-915.
46. Nichols B.J. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4:2002;374-378.
47. Parton R.G. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42:1994;155-166.
48. Wolf A.A., et al. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J. Cell Biol. 141:1998;917-927.
49. Shogomori H., Futerman A.H. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft- independent mechanism. J. Biol. Chem. 276:2001;9182-9188.
50. Torgersen M.L., et al. Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 114:2001;3737-3747.
51. Johannes L., Goud B. Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum? Trends Cell Biol. 8:1998;158-162.
52. Schapiro F., et al. pH-independent retrograde targeting of glycolipids to the Golgi complex. Am. J. Physiol. 274:1998;C319-C332.
53. Thomsen P., et al. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell. 13:2002;238-250.
54. Pelkmans L., et al. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:2001;473-483.
55. Pfeffer S.R. Rab GTPases: specifying and deciphering organelle identity and function. Trends Cell Biol. 11:2001;487-491.
56. Zerial M., McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2:2001;107-117.
57. Mallet W.G., Maxfield F.R. Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J. Cell Biol. 146:1999;345-359.
58. Abe A., et al. Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J. Clin. Invest. 105:2000;1563-1571.
59. Cabrera-Salazar M.A., et al. Gene therapy for the lysosomal storage disorders. Curr. Opin. Mol. Ther. 4:2002;349-358.
60. Schiffmann R., Brady R.O. New prospects for the treatment of lysosomal storage diseases. Drugs. 62:2002;733-742.
61. Schwarze S., et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.
62. Zhang M., et al. Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4466-4471.
63. Bertram E.M., et al. Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells. Int. Immunol. 14:2002;309-318.
64. Lebrand C., et al. Late endosome motility depends on lipids via the small GTPase Rab7. EMBO J. 21:2002;1289-1300.
65. Holtta-Vuori M., et al. Modulation of cellular cholesterol transport and homeostasis by rab11. Mol. Biol. Cell. 13:2002;3107-3122.
66. Holtta-Vuori M., et al. Mobilization of late-endosomal cholesterol is inhibited by Rab guanine nucleotide dissociation inhibitor. Curr. Biol. 10:2000;95-98.
67. Cavalli V., et al. Endocytosis and signaling cascades: a close encounter. FEBS Lett. 498:2001;190-196.
68. Benmerah A., et al. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J. Cell Sci. 112:1999;1303-1311.
69. Schnitzer J.E., et al. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127:1994;1217-1232.
70. Schubert W., et al. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276:2001;48619-48622.